Latest news and press releases about Nuwellis, Inc. (NUWE): earnings reports, analyst upgrades/downgrades, product launches, partnerships and regulatory filings. Stay updated on every market-moving event.
Nuwellis, Inc., a medical device company, develops, manufactures, and commercializes medical devices used in ultrafiltration therapy. The company provides Aquadex FlexFlow and Aquadex SmartFlow systems, which are used to treat patients suffering from fluid overload due to heart failure, as well as Aquadex SmartFlow system for temporary use in adult and pediatric patients. The company was formerly known as CHF Solutions, Inc. and changed its name to Nuwellis, Inc.
Price
| Price | $0.81 |
| Market Cap | $0M |
| Exchange | NASDAQ |
| Country | US |
Valuation Ratios
| Price / Book | -0.07 |
| EV / EBITDA | 0.50 |
| Dividend Yield | 0.00% |
Profitability
| Return on Equity | -605.75% |
| Return on Invested Capital | -238.32% |
| Return on Assets | -121.85% |
| Gross Margin | 69.69% |
| Operating Margin | -140.62% |
| Net Margin | -123.38% |
Related companies: ACON · BACK · BCTXW · IVF · NUVO · OCEA · PETV
Explore sector: Healthcare · Medical - Devices
More sections of NUWE: Overview · Financials · Valuation · Statistics · Estimates · Technical · Ownership · Events
Discover more: Radar — undervalued stock signals · Investment Academy — learn to analyze stocks